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ABBREVIATIONS 
TAILS: Terminal Amine Isotopic Labeling of Substrates; MMP: Matrix Metalloproteinase; 
PDGFR: Platelet-Derived Growth Factor Receptor; ADAM: A Disintegrin And Metalloproteinase 
domain-containing protein; ADAMTS: ADAM with Thrombospondin motifs; ADAMTSL: 
ADAMTS-like protein; SRM: Selected Reaction Monitoring; iTRAQTM: Isobaric Tag for Relative 
and Absolute Quantitation; GluC: Endoproteinase GluC; MMRRC: Mutant Mouse Regional 
Resource Center; MEF: Murine Embryonic Fibroblasts; DMEM: Dulbecco’s Modified Eagle’s 
Medium; FBS: Fetal Bovine Serum; HPG-ALD: Hyperbranched Polyglycerol Aldehydes; HCD: 
Higher Energy Collisional Dissociation; TPP: Trans Proteomic Pipeline; ROC: Receiver 
Operating Characteristic; PICS: Proteomic Identification of Protease Cleavage Sites; SBGN: 
Systems Biology Graphical Notation 
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SUMMARY 
Proteolysis is an irreversible post-translational modification that affects intra- and intercellular 
communication by modulating the activity of bioactive mediators. Key to understanding protease 
function is the system-wide identification of cleavage events and their dynamics in physiological 
contexts. Despite recent advances in mass spectrometry-based proteomics for high-throughput 
substrate screening, current approaches suffer from high false positive rates and only capture 
single states of protease activity. Here, we present a workflow based on multiplexed Terminal 
Amine Isotopic Labeling of Substrates (TAILS) for time-resolved substrate degradomics in 
complex proteomes. This approach significantly enhances confidence in substrate identification 
and categorizes cleavage events by specificity and structural accessibility of the cleavage site. 
We demonstrate concomitant quantification of cleavage site spanning peptides and neo-N 
and/or neo-C termini to estimate relative ratios of non-cleaved and cleaved forms of substrate 
proteins. By applying this strategy to dissect the matrix metalloproteinase 10 (MMP10) substrate 
degradome in fibroblast secretomes, we identified the extracellular matrix protein ADAMTS-like 
protein 1 (ADAMTSL1) as a direct MMP10 substrate and revealed MMP10-dependent 
ectodomain shedding of platelet-derived growth factor receptor alpha (PDGFRα) as well as 
sequential processing of type I collagen. The data have been deposited to the 
ProteomeXchange Consortium with identifier PXD000503. 
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INTRODUCTION 
Historically regarded as a mechanism for unspecific degradation of proteins, proteolysis is now 
recognized as a specific irreversible post-translational modification that affects major intra- and 
intercellular signaling processes (1, 2). Proteases specifically process bioactive proteins, their 
receptors, and associated proteins in an interconnected interaction network termed the protease 
web (3). Dysregulation of the protease web might cause or result from pathologies, such as 
impaired tissue repair, cancer and neurodegenerative diseases. Therefore, a better 
understanding of the functions of individual proteases and their interconnections within 
proteolytic networks is a prerequisite for exploiting proteases as targets for therapeutic 
intervention (4). 
To address this issue, several powerful technologies have been developed for the system-wide 
discovery of protease substrates, i.e. substrate degradomes, in complex and active proteomes 
(5, 6). A common principle of these mass spectrometry-based methods is the enrichment and 
monitoring of N-terminal peptides (protein neo-N termini) that are newly generated by a test 
protease (7). Protein N termini are enriched from complex proteomes either by chemical tagging 
and affinity resins (positive selection) or by depletion of internal peptides (negative selection) 
(7). Both principles have been successfully applied in various studies to characterize N-
terminomes and to identify protease substrates using in vitro or cell-based systems and more 
recently also in vivo (8, 9). Negative enrichment approaches were further extended to the 
analysis of protein C termini (10, 11) and have the general advantage of recording data on 
naturally blocked (e.g. acetylated) N termini and internal peptides in the same experiment (8). 
Even if successful in identifying novel proteolytic cleavage events, which could also be validated 
by orthogonal methods, high-throughput substrate discovery approaches potentially suffer from 
high numbers of false positive identifications, particularly when employing in vitro systems (12). 
These have been reduced by monitoring abundances of N-terminal peptides at multiple time 
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points after incubation of a proteome with a test protease (12). In this SILAC-based approach 
the authors efficiently distinguished critical from bystander cleavages, but it was limited to three 
time points. Therefore, it did not allow recording kinetic profiles of the relative abundance of N-
terminal peptides that are required for determination of apparent kinetic parameters for 
processing events. Agard et al. elegantly overcame this limitation by use of selected reaction 
monitoring (SRM) in combination with a positive N-terminal enrichment platform and determined 
apparent catalytic efficiencies for hundreds of caspase cleavage events in parallel (13). In a 
similar approach the same group characterized cellular responses to pro-apoptotic cancer drugs 
by recording time-courses for caspase-generated neo-N termini (14). While very powerful and 
highly accurate in quantification, this method strongly exploited the canonical cleavage 
specificity of caspases after aspartate residues and required a two-stage process involving two 
types of mass spectrometers. Hence, it would be desirable to monitor the time-resolved 
generation of neo-N termini in complex proteomes in a single experiment by a simple and robust 
workflow in an unbiased manner. 
The development of such an analysis platform would require a reliable method for the system-
wide characterization of protein N termini that is easy to perform, fast and highly multiplexible. 
All these criteria are met by iTRAQ-TAILS, a multiplex N-terminome analysis technique that has 
been applied in 2plex and 4plex experiments to map the matrix metalloproteinase (MMP) 2 and 
MMP9 substrate degradomes in vitro (15) and most recently to quantitatively analyze the 
proteome and N-terminome of inflamed mouse skin in the presence or absence of the immune-
modulatory protease MMP2 in vivo (8). 
Here, we exploited the multiplex capabilities of iTRAQ-TAILS by use of 8plex-iTRAQ reagents to 
monitor the generation of neo-N-terminal peptides by a test protease in complex samples over 
time. First, using GluC as a test protease with canonical cleavage specificity, we established a 
workflow for time-resolved substrate degradomics. Recording kinetic profiles significantly 
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increased the confidence in identified cleavage events compared to binary systems and 
categorized primary cleavage specificities as well as secondary structure elements based on 
clusters of processing events with different efficiencies. By including data from before N-terminal 
enrichment, we extended our analysis to neo-C-terminal peptides and concomitantly monitored 
the generation of neo-N termini and neo-C termini as well as the decrease in abundance of the 
tryptic peptides spanning the cleavage site in the same experiment. Next, we applied this 
approach to the time-resolved analysis of the hardly elucidated substrate degradome of matrix 
metalloproteinase 10 (MMP10). This important wound- and tumor-related protease is secreted 
by proliferating and migrating keratinocytes at the wound edge in close proximity to dermal 
fibroblasts and is also highly expressed in aggressive tumor cells (16-18). Our analysis revealed 
MMP10-dependent shedding of the platelet-derived growth factor receptor alpha (PDGFRα), 
processing of ADAMTS-like protein 1 (ADAMTSL1) and multiple cleavages of type I collagen, 
which could be validated and classified by time-resolved abundance profiles of their 
corresponding neo-N termini. 
EXPERIMENTAL PROCEDURES 
Cell growth and preparation of secreted proteins. Mmp10-/- mice were obtained from the 
Mutant Mouse Regional Resource Center (MMRRC) at UC Davis (strain# 011737-UCD), and 
immortalized murine embryonic fibroblasts (MEF) isolated from 13.5 day old embryos were 
established by continuous passaging following the 3T3 protocol (19). Balb/c 3T3 fibroblasts 
were cultured in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 1% 
penicillin/streptomycin and 10% fetal bovine serum (FBS), Mmp10-/- MEFs were cultured in the 
same medium plus 0.1 mM nonessential amino acids and 55 µM β-mercaptoethanol, and 
secreted proteins were collected as described previously (20). Briefly, cells were washed with 
phosphate buffered saline (PBS), incubated in serum-free DMEM lacking phenol red for 24 h, 
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and supernatants supplemented with protease inhibitors (0.5 mM PMSF and 1 mM EDTA) were 
concentrated by ultrafiltration with 3 kDa cutoff membranes (Amicon). After exchange of 
medium to 50 mM HEPES buffer (pH 7.8), the Bradford assay (BioRad) was used to determine 
protein concentration, which was adjusted to 2 mg/ml protein and 250 mM HEPES (pH 7.8) with 
1 M HEPES, pH 7.8. Aliquots of 0.25 mg of concentrated culture supernatants were prepared 
and stored at -80 °C until further use. 
Digestion of secretomes with proteases. Concentrated (~500x) Balb/c 3T3 secretomes were 
incubated with GluC (Roche) at an enzyme:protein ratio of 1:100 (w/w) for up to 16 h at 37 °C. 
Auto-activated (16 h at 37 °C) MMP10 (R&D Systems) was added to concentrated (~600x) 
supernatants from Mmp10-/- MEFs (220 nM final concentration; 1:170 enzyme:protein ratio 
(w/w)) and incubated for up to 16 h at 37 °C in the presence of 10 mM CaCl2 and 100 mM NaCl. 
Control samples (no protease) were incubated with an equivalent volume of buffer only, and 
protein preparations from the same batch were used for each condition of individual 
experiments. 
8plex-iTRAQ-TAILS protocol. iTRAQ-TAILS analysis followed the previously published 
protocol (21) but used 8plex- (22) instead of 4plex-iTRAQ reagents. Aliquots of 0.25 mg of 
protease-treated or control secretomes were labeled using 8plex-iTRAQ reagents in a 1:4 
protein:iTRAQ (w/w) ratio. After tryptic digest (TrypsinGold, Promega; 1:100 enzyme:protein 
(w/w)) 10% of the peptide mixture were removed for analysis prior to enrichment for N-terminal 
peptides. The remaining 90% were depleted for internal tryptic peptides using a 435 kDa HPG-
ALD polymer in 3-fold excess (w/w) and under previously described conditions (21). Samples 
were frozen and stored at -20 °C until further use. 
Peptide fractionation and LC-MS/MS analysis. Peptide mixtures from both prior and after 
enrichment for protein N termini were fractionated by strong cation exchange chromatography 
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(SCX) using a PolySULFOETHYL ATM 100 mm × 2.1 mm, 5 µm, 200 Å column (PolyLC Inc.) 
and an Agilent Technologies 1100 series HPLC system (Agilent Technologies). Peptides were 
bound to the column, washed with 100% buffer A (10 mM potassium phosphate, 25% 
acetonitrile, pH 2.7) for 60 min and eluted by gradually increasing buffer B (buffer A + 0.5 M 
potassium chloride) to 5% within 5 min, then to 35% within 35 min, and finally to 100% within 10 
min. Twenty-seven fractions were collected and pooled to 8 fractions during sample clean up 
using C18 OMIX tips (Agilent Technologies) and according to the 214/280 nm absorption 
chromatogram. Peptide fractions from GluC and MMP10 experiments were analyzed on an 
LTQ-Orbitrap XL (XL) or an LTQ-Orbitrap Velos (Velos) mass spectrometer (Thermo Fischer 
Scientific), respectively, coupled to an Eksigent-Nano-HPLC system (Eksigent Technologies). 
One microgram of peptides were loaded onto a self-made tip column (XL: 75 µm x 70 mm; 
Velos: 75 µm x 150 mm) packed with C18 material (AQ, 3 µm 200 Å, Bischoff GmbH) and 
eluted with a flow rate of 200 nl/min using a gradient from 0 to 37% of acetonitrile in 55 min 
(Velos: 250 nl/min, 35% acetonitrile in 62 min). Full scan MS spectra (XL: 300-2000 m/z; Velos: 
300-1700 m/z) were acquired with a resolution of 60000 (XL) or 30000 (Velos) at 400 m/z after 
accumulation to a target value of 5E5 (XL) or 1E6 (Velos). Collision induced dissociation (CID) 
MS/MS spectra were recorded in a data dependent manner in the ion trap from the three (XL) or 
eight (Velos) most intense signals above a threshold of 500 (XL) or 1000 (Velos) using a 
normalized collision energy of 35% and an activation time of 30 ms (XL) or 10 ms (Velos). To 
obtain spectral information in the region of iTRAQ report ions, the same precursors were further 
fragmented using higher energy collisional dissociation (HCD) with a normalized collision 
energy of 42% (XL) or 45% (Velos), and the spectra were recorded at a resolution of 7500 at 
400 m/z. Charge state screening was enabled, and single charge states were rejected. 
Precursor masses already selected for MS/MS were excluded for further selection for 90 s (XL) 
or 45 s (Velos), and the exclusion window was set to 20 ppm. 
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MS data analysis. Mascot Distiller v2.4.3.3 (Matrix Science) was used to extract peak lists from 
raw files and for merging of corresponding CID/HCD spectra pairs. Peak lists (mgf) were 
searched by Mascot v2.3 search engine (Matrix Science) against a mouse UniProtKB database 
(release 2012_03; 54232 entries), to which reversed decoy sequences as well as sequences for 
common contaminants and either for GluC or for human MMP10, respectively, had been added 
and with following parameters: semi-Arg-C for enzyme specificity allowing up to 2 missed 
cleavages; carbamidomethyl(C), iTRAQ(K) as fixed modifications; acetyl(N-term), iTRAQ(N-
term), oxidation(M), and deamidation(NQ) as variable modifications; parent mass error at 10 
ppm, fragment mass error at 0.8 Da. For GluC experiments an additional search was performed 
using the same parameters but with semi-GluC as enzyme and allowing up to 5 missed 
cleavages. The Trans-Proteomic Pipeline (TPP v4.6, rev 1, Build 201212051643) (23) was used 
to secondary validate Mascot search results and to compile a single peptide list from all peptide 
fractions obtained from both the pre-pullout and the pullout samples. First, data were processed 
by PeptideProphet setting the ‘minimum peptide length’ to 1, using ‘accurate mass binning’ and 
omitting the ‘NTT model’. Next, iProphet was employed for additional validation and for 
combining PeptideProphet results from multiple searches, and only peptides with an iProphet 
probability of ≥0.9 (corresponding to false discovery rate (decoy) of <1%) were included in 
subsequent analyses. For relative quantification iTRAQ reporter ion intensities were extracted 
from mgf files using a modified version of i-Tracker (24) with a mass tolerance of 0.1 Da and 
purity corrections supplied by the iTRAQ manufacturer and assigned to filtered peptides. 
Peptide annotation, clustering and generation of sequence logos. Multiple CIDs were 
merged, and peptides were assigned to proteins and annotated for their position in the 
processed mature protein using the CLIPPER analysis pipeline (25). iTRAQ reporter ion 
intensities were normalized to the sum of all channels and a maximum of 1.0 for the highest 
value, and abundance clustering was performed using the Mfuzz package for R (26) and the 
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mestimate() function to determine optimal fuzzication parameters (27). The R statistical 
environment (version 2.15.3) in combination with RStudio (http://www.r-project.org/) and Prism 
5.0 (GraphPad Software) were used for curve fitting, and ROC curve analysis was performed 
using the ROCR package (28). Cleavage site specificities were calculated by WebPICS (29), 
and logos were generated using IceLogo (30). Secondary structures were predicted using a 
local installation of the PROTEUS2 algorithm (31) and visualized using WebLogo (32). Systems 
Biology Graphical Notation (SBGN) map was generated using CellDesigner (33, 34). 
Immunoblot analysis and zymography. Concentrated cell culture supernatants from Mmp10-/- 
MEFs were incubated with recombinant MMP10 as described for iTRAQ-TAILS experiments. 
For immunoblot analyses equal amounts of total protein were resolved by SDS-PAGE, 
transferred to nitrocellulose membranes (Whatman) and probed with antibodies directed against 
collagen I (Chemicon), MMP2 (Novus Biologicals) or PDGFRα (R&D Systems). Recombinant 
ADAMTSL1 was analyzed using an antibody raised against a peptide in the thrombospondin 
domain 2 (35). Bands were visualized using horseradish peroxidase conjugated secondary 
antibodies and the enhanced chemiluminescence (ECL) reaction by exposing the membranes 
to an X-ray film (Fuji Medical). 
Gelatinolytic activity in sectretomes incubated with MMP10 was visualized by gelatin 
zymography using SDS-PAGE with 1 mg/ml gelatin, and casein zymography was performed 
with gels containing 1 mg/ml casein. 
Substrate cleavage assays. Recombinant human PDGFRα (residues 24-524) was purchased 
from R&D Systems, and recombinant human ADAMTSL1 (isoform 1) was expressed and 
purified as described previously (35). Auto-activated MMP10 (16 h at 37° C) was incubated with 
the candidate substrates in 50 mM Tris-HCl, 200 mM NaCl and 5 mM CaCl2 for 16 h at 37 °C. 
Reaction products were analyzed by SDS-PAGE and visualized by silver stain or immunoblot. 
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The mass spectrometry proteomics data have been deposited to the ProteomeXchange 
Consortium (http://proteomecentral.proteomexchange.org) via the PRIDE partner repository (36) 
with the dataset identifier PXD000503. 
RESULTS 
Experimental setup and peptide classification 
To establish a workflow for the time-resolved analysis of proteolysis in complex samples we 
subjected cell culture supernatants from Balb/c 3T3 mouse fibroblasts that had been incubated 
with the endoproteinase GluC (Staphylococcus aureus protease V8) as test protease for 1, 2, 4, 
8, and 16 hours or buffer alone (0, 12, and 16 hours controls) to 8plex-iTRAQ-TAILS analysis 
(Figure 1A). By combining samples prior to and after enrichment of N-terminal peptides, we 
identified a total of 3017 semi-tryptic N-terminal or fully tryptic internal peptides (Supplemental 
Table S1), of which 1645 could be quantified either via an N-terminal or a lysine iTRAQ-label. 
GluC specifically cleaves substrate proteins C-terminal to glutamate (E) and with a much lower 
efficiency after aspartate (D) residues (37, 38). Trypsin as the working protease generated 
defined quantifiable peptides of two major classes (Figure 1B): i) cleavage events: semi-GluC, 
semi-tryptic neo-N termini (E/D.iTRAQX-R) and semi-tryptic, semi-GluC neo-C termini (R.X-KiTRAQ-
X-E/D); ii) non-cleavage events: non-GluC, semi-tryptic natural N termini (iTRAQ(Ac)M(X).X-
(KiTRAQ)-R) and fully tryptic internal peptides (R.X-KiTRAQ-X-R). Since incubation of a non-
denatured proteome with GluC yields only incomplete digestion even after 16 hours (20) 
resulting in numerous missed cleavages, peptides of all classes could be subdivided into those 
harboring a glutamate or aspartate within their sequence (missed cleavage site) or not. 
However, because the interpretation of time-resolved data from multiple overlapping cleavage 
events would not allow meaningful conclusions, we only included peptides with a single missed 
cleavage site. This allowed also monitoring either degradation of non-GluC, semi-tryptic natural 
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N termini and of fully tryptic internal peptides by internal cleavage as well as secondary 
cleavages of neo-N-terminal peptides. 
High confidence classifier for cleavage events based on time-dependent abundances 
A major challenge in the interpretation of high-throughput degradomics datasets is the 
discrimination between cleavage events and non-cleavage events. In a previous approach the 
canonical cleavage site specificity of GluC was exploited to establish a classifier for cleavage 
events based on abundance ratios of N-terminal peptides in GluC-treated and control samples 
(20). While this strongly increased the confidence in substrate identification, it was nevertheless 
associated with relatively high false discovery rates of around 15%. To establish a classifier with 
higher sensitivity and specificity, we extracted a sub-dataset of neo-N-terminal peptides derived 
from known single cleavage events (neo-N termini) and known non-cleavage events (natural N 
termini and internal tryptic peptides) (Figure 1B; Supplemental Table S2). Next, we used fuzzy c 
means clustering that is particularly suited for the analysis of data from time course analyses 
(39) to assign peptides to two clusters based on their relative abundances in all eight samples 
(Figure 1C). As expected, the abundance of peptides in cluster N.1 increased in a time-
dependent manner and was low in all three control samples, while the abundance of peptides in 
cluster N.2 was relatively constant in all samples. Cleavage specificity logos generated by 
WebPICS (29) and IceLogo (30) revealed that cluster N.1 indeed comprised peptides derived 
from GluC-dependent cleavage events (E/D in P1 position; neo-N termini), while peptides 
generated by trypsin and after GluC treatment of the proteome (time-independent) were 
assigned to cluster N.2 (M (initiator methionine) in P1: natural N-termini or R in P1: internal 
tryptic peptides) (Figure 1D). As observed in previous studies, natural N termini commencing 
after an initiator methionine are derived from cytoplasmic proteins released into the secretome 
under these culture conditions (20). In fuzzy clustering peptides can belong to multiple clusters, 
and their degree of assignment to a specific cluster is determined by the so-called membership 
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value α. We exploited this relation to establish a classifier for cleavage versus non-cleavage 
events based on cluster membership values. This classifier showed an excellent performance in 
receiver operating characteristic (ROC) analysis with an optimal true positive rate of 98% at a 
false discovery rate of <5% and a membership value threshold of 0.61 (Figure 1E). 
Monitoring neo-C-terminal peptides 
Although TAILS focuses on N-terminal peptides and thereby on monitoring neo-N termini 
generated by proteolytic cleavage, we tested if including data from analysis prior to N-terminal 
enrichment also allows analyzing neo-C-terminal peptides. For this purpose we combined 
peptides with a trypsin-generated N and a GluC-derived C terminus that harbored an iTRAQ-
labeled lysine within their sequence and thus were quantifiable (Figure 1B; neo-C termini; 
cleavage events) with our dataset of known non-cleavage events (natural N termini and internal 
tryptic peptides) (Supplemental Table S3). Again, we applied fuzzy c means clustering to this 
sub-dataset and could separate neo-C termini derived from GluC activity from non-cleavage 
events (Figure 1F). Furthermore, ROC analysis defined a similar performance of a classifier 
based on cluster membership values as for neo-N termini and an optimal threshold of 0.62 
(Figure 1E). This demonstrated the efficient identification of neo-C termini by time-resolved 
8plex-iTRAQ-TAILS analysis. 
Kinetic sub-classification of cleavage site specificity and structural accessibility 
In a next step, we further sub-classified neo-N-terminal peptides assigned with a membership 
value of at least 0.61 and thus with high confidence to cluster N.1 (cleavage events). Thereby, 
three sub-clusters of peptides with distinct kinetics of time-dependent abundance after 
incubation with GluC could be formed (Figure 2A) (Supplemental Table S4), which was in 
agreement with a previous kinetic analysis of proteolysis in a complex proteome (13). For strict 
assignment of peptides to distinct clusters, we only included peptides with membership values 
of ≥0.8. Using the well-established equation for pseudo-first order kinetics we determined a 
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range of apparent kcat/Km values of 400-800 M-1s-1 for cleavage events in sub-cluster N.1.2 that 
comprised abundance profiles in a measurable range (13) (Supplemental Figure S1). To further 
characterize cleavage events in each sub-cluster, we again generated IceLogos for cleavage 
site specificities (Figure 2B). These indicated assignment of GluC cleavages after aspartate to 
sub-cluster N.1.1 of peptides derived from the least efficient cleavage events. Moreover, 
WebLogo representations of secondary structures showed a predominance of loops for 
cleavages after glutamate for highly efficient processing events when compared to cleavages 
with lower efficiency (Figure 2C). Notably, for six proteins, cleavages C-terminal to glutamate 
within the same protein were assigned to two or three clusters, indicating multiple cleavages at 
different sites and with different efficiencies. Related to protein structures, low efficiency 
cleavage sites were located in helices or sheets, whereby sites in loops were processed with 
higher efficiency (Figure 2D). Therefore, 8plex-iTRAQ-TAILS kinetic analysis of proteolytic 
processing in complex proteomes could effectively categorize primary cleavage site specificities 
and structural accessibility. 
Decreasing abundances of peptides with internal cleavage sites 
Having established kinetic models for monitoring the time-resolved generation of neo-N and 
neo-C termini by kinetic 8plex-iTRAQ-TAILS, we analyzed abundance profiles for natural N 
termini and internal fully tryptic peptides that harbor a single glutamate or aspartate in their 
sequence (Figure 3A; cleavage events). Following the same principle of distinguishing these 
potential known cleavages from known non-cleavage events by their time-dependent 
abundance upon GluC incubation, a sub-dataset comprising peptides derived from these 
cleavage events and known non-cleavage events (Figure 3A; internal tryptic peptides and 
natural N termini; Supplemental Table S5) was assigned to two clusters (Figure 3B). As 
expected, 100% of peptides assigned to cluster I.1 (α ≥0.8) displaying a time-dependent 
decrease in abundance after GluC incubation where either natural N termini or internal tryptic 
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peptides harboring an E or D in their sequence, whereby cluster I.2 comprised 41% natural N 
termini and internal tryptic peptides with and 59% without internal E or D residues. Furthermore, 
78% of peptides in cluster I.1 harbored a glutamate in their sequence and 22% an aspartate, 
whereas this ratio was 36% (E) to 64% (D) for E or D containing peptides in cluster I.2. Again, 
this is in agreement with the higher efficiency of GluC towards cleavage after glutamate than 
aspartate and the structural inaccessibility of many potential cleavage sites to the protease. For 
5 of the 20 peptides with time-dependent decrease in abundance in cluster I.1 we also identified 
the corresponding neo-N termini, which concomitantly showed an increase in abundance as 
exemplified for an internal tryptic peptide in Figure 3C. This cleavage event was further 
complemented by detection of the neo-C-terminal peptide, revealing all three events, i.e. the 
decreasing abundance of the internal tryptic peptide and increasing abundances of both the 
neo-N-terminal and the neo-C-terminal peptides that all showed the same kinetics (Figure 3C). 
Consequently, quantitative analyses of the decrease of a tryptic peptide and the increase of 
either the corresponding neo-N terminus or neo-C terminus allows estimating ratios of non-
cleaved and cleaved forms of substrate proteins. 
Influence of secondary cleavage events on neo-N termini 
A particular advantage of monitoring protease cleavage events over time is the possibility to 
also capture neo-N-terminal peptides that upon initial increase decrease in abundance due to 
additional cleavage by either the generating or a different protease within the time frame of the 
experiment. Thereby, the decrease in abundance of a neo-N terminus could result from a 
second limited proteolysis event or from unspecific degradation of the truncated form of the 
substrate. To test if kinetic 8plex-iTRAQ-TAILS detects these events, we analyzed abundance 
profiles of GluC-derived neo-N termini that harbor a single glutamate or aspartate within their 
sequence. As expected from the high number of missed cleavages identified in our analysis of 
internal cleavage sites (Figure 3B), fuzzy c means clustering of neo-N-terminal peptides with a 
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single missed cleaved E or D residue yielded three clusters associated with increasing cleavage 
efficiencies similar to neo-N termini, which do not harbor an E or D in their sequence 
(Supplemental Figure S2; Supplemental Table S6; clusters NE.1 to NE.3). However, 20 neo-N 
termini of this class were assigned to a fourth cluster NE.4 based on their continuous decrease 
in abundance after 2 to 4 hours following an initial rapid increase after GluC incubation 
(Supplemental Figure S2 and Figure 3D). This abundance profile could be explained by a highly 
efficient upstream cleavage and a much slower secondary processing event. This could be 
governed by differences in the primary cleavage site sequence (glutamate versus aspartate in 
P1). Indeed, we could identify for a secondary cleavage event also the corresponding second 
neo-N terminus (Figure 3E), which was generated after an aspartate in combination with an 
upstream cleavage after glutamate. Thus, time-resolved 8plex-iTRAQ-TAILS allows detecting 
cleavage events that are affected by secondary cleavages and would be missed in a 2plex 
experiment monitoring only a single time point. 
Identification of MMP10-dependent cleavage events by time-resolved analysis 
Having established 8plex-iTRAQ-TAILS for time-resolved analysis of proteolytic cleavage 
events using GluC as a test protease with canonical cleavage specificity, we applied the 
modified method to identification of new cleavages mediated by MMP10, an important wound 
and tumor protease, for which only very few substrates are known (16-18). For this purpose we 
incubated supernatants from MMP10-deficient immortalized murine embryonic fibroblasts (MEF) 
with auto-activated recombinant MMP10 for 1, 2, 4, 8, 12 and 16 h or buffer alone (0 and 16 h 
controls) and recorded time-resolved abundance profiles of resulting peptides by 8plex-iTRAQ-
TAILS (Figure 4A). We used a concentration of recombinant MMP10 that was 100- to 500-fold 
higher than levels of endogenous MMP10, which have been measured in cell culture 
supernatants (40, 41). However, secretomes were 600x concentrated prior to incubation with 
the protease, resulting in a similar enzyme:protein (w/w) ratio. These parameters have been 
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chosen based on previous studies (15, 20, 42), but actual enzyme activities might considerably 
differ in vivo. Importantly, activated MMP10 was stable over the entire time of incubation as 
shown by casein zymography and TAILS analysis of the N termini of the mature and active 
protease (Supplemental Figure S3). We identified 385 semi-tryptic N-terminal and 1264 fully 
tryptic internal peptides (Supplemental Table S7), from which we extracted a sub-dataset of 221 
peptides resulting from potential cleavage events (semi-tryptic neo-N termini) as well as 521 
peptides derived from expected non-cleavage events (51 quantifiable natural N termini and 470 
quantifiable fully tryptic internal peptides) (Figure 4B; Supplemental Table S8). Fuzzy c means 
clustering of this sub-dataset and a stringent α-value threshold of 0.9 robustly discriminated 
between 67 peptides with time-dependent increase in abundance (cluster M.1) and 464 
peptides with relatively constant abundance in all samples (cluster M.2) (Figure 4C). Based on 
data for neo-N termini in the GluC test experiment, we extracted 38 peptides from cluster M.1 
that had relative abundance values of less than 25% of the maximum abundance in both control 
channels (0 and 16 h). This step efficiently excluded peptides, which might have been 
generated by basal proteolysis. IceLogo analysis of the 38 corresponding cleavage sites 
revealed high occurrences of proline in P3 and leucine or isoleucine in P1’, which are indicative 
of MMP-mediated processing (15, 20), suggesting that indeed most of the observed neo-N 
termini had been generated either directly by MMP10 or another MMP that is activated by 
MMP10 (Figure 4D). The same analysis of cleavage sites corresponding to peptides in cluster 
M.2 yielded a high prevalence of arginine in P1 and thus of fully tryptic internal peptides, 
demonstrating the general stability of the proteome during the time of incubation with the test 
protease. Notably, 211 peptides could not be assigned to any of the two clusters by our 
selection criteria, strongly enhancing the confidence in identification of bona fide MMP10-
dependent cleavage events. 
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Sub-classification of MMP10-dependent cleavage events by kinetic sub-clustering 
Next, we assigned 23 of the 38 filtered peptides in cluster M.1 to two sub-clusters with either 
slow (sub-cluster M.1.1; 13 peptides) or fast (sub-cluster M.1.2; 10 peptides) increase in 
abundance over time (Figure 5A; Supplemental Table S9). Applying a stringent threshold for the 
alpha value of 0.8 further narrowed in on neo-N termini that were generated in response to 
MMP10-mediated processing. Analysis of cleavage site specificities by IceLogo determined 
different types of substrates in each sub-cluster (Figure 5B). While the majority of cleavages in 
sub-cluster M.1.1 (slow) exhibited the typical GPXG.L/I cleavage motif in collagen α chains (43), 
substrates in sub-cluster M.1.2 (fast) were cleaved at sites with P in P3 and/or L/I in P1’ but 
were almost all non-collagen proteins (Figure 5C). Interestingly, the only collagen cleavage 
assigned to sub-cluster M.1.2 and thus to the group of more efficient cleavages corresponded to 
the canonical MMP processing site in the collagen α2(I) chain after position 871, which leads to 
generation of the typical ¾ and ¼ fragments (43). Since cleavages within the same protein were 
assigned to both sub-clusters, we could discriminate between a known efficient processing 
event at a structurally accessible site and additional less efficient cleavages at more occluded 
sites by time-resolved iTRAQ-TAILS analysis (Figure 5D). 
Confirming these data immunoblot analysis of MMP10-treated secretomes from Mmp10-/- MEFs 
revealed appearance of type I collagen cleavage fragments at different time points of incubation 
(Figure 5E). Although MMP10 can cleave type III, IV and V collagen, it has never been shown to 
have direct activity towards type I collagen (44). This suggested processing of the collagen α2(I) 
chain by an endogenous collagenolytic MMP upon activation by exogenous MMP10. Indeed, 
gelatin zymography analysis of MMP10-incubated secretomes from Mmp10-/- MEFs identified a 
band that increased with time of incubation and correlated to the molecular weight of activated 
MMP2. This result could be further validated by immunoblot analysis of the same samples using 
an MMP2 specific antibody (Figure 5E). 
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Indirect cleavage of PDGFRα  and direct processing of ADAMTSL1 by MMP10 
Among proteins that were efficiently processed upon incubation of secretomes from Mmp10-/- 
MEFs with MMP10 (sub-cluster M.1.2), we identified the platelet-derived growth factor receptor 
alpha (PDGFRα) by a neo-N terminal peptide starting at position 417 within the extracellular 
domain (Figure 6A). Immunoblotting of MMP10-treated Mmp10-/- MEF secretomes with a 
PDGFRα specific antibody confirmed this cleavage and the MMP10-dependent generation of 
two fragments of expected molecular weights of ~80 and ~40 kDa, respectively. However, 
recombinant human PDGFRα protein (residues 24-524; extracellular domain) was not cleaved 
by direct incubation with recombinant human MMP10 in vitro, indicating a similar indirect 
processing event as for collagen α2(I) by an MMP10-activated endogenous protease. 
Interestingly, recombinant MMP2 also did not directly process the extracellular domain of 
PDGFRα (Supplemental Figure S4), suggesting the activity of a different protease towards this 
protein. 
Within the same cluster of efficient MMP10-dependent cleavages the extracellular matrix protein 
ADAMTS-like protein 1 (ADAMTSL1), also known as Punctin 1 (35), was identified by a neo-N 
terminus corresponding to a cleavage site between the thrombospondin domains 2 and 3 
(Figure 6B). SDS-PAGE and silver staining revealed cleavage fragments of the expected 
molecular weights (~40 and ~20 kDa) of human recombinant ADAMTSL1 upon incubation with 
active recombinant MMP10 and thus identified ADAMTSL1 as a direct MMP10 substrate. This 
cleavage could be further confirmed by immunoblot analysis using an antibody directed against 
a peptide within the thrombospondin domain 2 of ADAMTSL1 that detected the ~40 kDa N-
terminal cleavage fragment. Although less efficiently, MMP2 also cleaved ADAMTSL1 into 
fragments of the same sizes (Supplemental Figure S4), suggesting cooperative processing of 
ADAMTSL1 by both MMP10 and MMP2. 
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DISCUSSION 
Recent advances in positional proteomics have enabled the reliable identification of protease 
substrates in complex biological samples (5). Evolving these powerful technologies further, we 
present a workflow for the time-resolved monitoring of protein termini by exploiting the multiplex 
capabilities of the recently introduced iTRAQ-TAILS analysis platform (15, 21). Time-resolved 
8plex-iTRAQ-TAILS significantly enhanced the confidence in validity of recorded cleavage 
events for both protein N and C termini and efficiently classified cleavages by sequence and 
structural accessibility of the cleavage site. Moreover, we identified cleavage events by 
decrease in abundance of cleaved peptides and determined ratios for cleaved and non-cleaved 
forms of target proteins by concomitant quantification of the neo-N terminus, the neo-C terminus 
and the peptide spanning the cleavage site. Finally, we applied this approach to the analysis of 
the MMP10 substrate degradome in fibroblast secretomes and revealed direct processing of 
ADAMTSL1 as well as MMP10-dependent ectodomain shedding of PDGFRα and sequential 
processing of type I collagen, which might be mediated by activation of proMMP2 (Figure 7). 
With our time-resolved 8plex-iTRAQ-TAILS analysis we determined relative proteolytic 
efficiencies of multiple cleavage events in complex proteomes, a major challenge in current 
substrate degradomics (6). Extending a recent study that used SRM to record catalytic 
efficiencies of pre-determined cleavage events (13), we exploited kinetic abundance profiles of 
N-terminal peptides to significantly enhance sensitivity in distinguishing cleavage from non-
cleavage events. This decreased the total number of identified cleavage sites compared to 
previous analyses (15, 20) and concomitantly removed many bystander events, which are 
presumably contaminating datasets obtained in experiments that compare treatment with a 
single protease to a control sample (12). In the original bioinformatics analysis pipeline for 
TAILS data (‘CLIPPER’), only N-terminal peptides were included in the dataset, while separate 
analyses of samples prior to N-terminal enrichment were primarily used to increase confidence 
  Time-resolved substrate degradomics 
 21 
in protein identification (25). In our modified approach, we composed an integrated dataset of all 
peptides before and after enrichment of protein N termini. Thereby, the dataset is vastly 
expanded by quantifiable internal tryptic peptides, which could be released from proteins by the 
working protease (trypsin) with only low variability in abundance at each time point of incubation 
with the test protease (GluC). This gives some indication of the relative stability of the proteome 
over time, since multiple unspecific cleavages would have led to decrease in abundance of a 
significant number of internal tryptic peptides. Moreover, the expanded dataset allowed reliable 
identification of neo-C termini by monitoring quantifiable N-terminally tryptic and C-terminally 
non-tryptic peptides and identification of cleavage events by decrease in abundance of 
processed peptides. If these peptides spanning the cleavage site were quantified in addition to 
neo-N and/or neo-C termini, it was even possible to determine relative abundances of full-length 
and truncated forms of substrate proteins. 
Most importantly, time-resolved analysis allowed sub-classification of protease cleavage events 
by catalytic efficiency. Our results obtained by fuzzy c means clustering are comparable to data 
from Agard et al. yielding clusters of cleavage events mainly below, within and above a 
measurable range (13). Within a measurable range we determined an apparent kcat/Km value for 
GluC of 4-8 * 102 M-1s-1, which is two orders of magnitude lower than the published value for a 
chromogenic peptide substrate (45). This is expected, since in our experimental setup GluC 
acts on protein substrates within a complex and native proteome, resulting in much lower 
catalytic efficiencies and a high number of missed cleavages. Hence, time-resolved 8plex-
iTRAQ-TAILS provides a powerful method to determine intrinsic catalytic efficiencies of multiple 
cleavage events in complex proteomes in parallel. 
Since processing by the GluC endoproteinase is hardly or not at all affected by specific non-
catalytic protease substrate interactions, differences in catalytic efficiencies are either mediated 
by sequence or structural constraints of the cleavage site. Thereby, GluC cleaves with two 
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orders of magnitude lower efficiency after aspartate than glutamate residues (46). Time-
resolved 8plex-iTRAQ-TAILS analysis resolved this specificity by constraining cleavages with 
aspartate in P1 to the cluster resembling the least efficient cleavage events. Using N-
terminomics Timmer et al. identified extended loops and helices as preferred secondary 
structures for cleavage by GluC (47). Our time-resolved analysis corroborates this finding and 
extends it by the expected observation that GluC cleaves extended loops with higher efficiency 
than helices and sheets, which is also the case for multiple cleavages within the same protein. 
Strikingly, kinetic 8plex-iTRAQ-TAILS distinguished the canonical MMP processing site in triple-
helical collagen from additional cleavages in structurally less accessible regions of the protein 
(48). Thus, adding time-resolved quantitative information to N-terminomics analyses provides 
data to probe for cleavage site specificity and structural accessibility in native protein substrates. 
To validate and prove the extended capabilities of our workflow for time-resolved monitoring of 
proteolytic events in complex proteomes, we analyzed the MMP10 substrate degradome. 
MMP10 is an important wound and tumor protease, which is highly expressed in migrating 
keratinocytes and believed to mediate epithelial cell migration by controlling processes at the 
epidermal-dermal interface in the healing skin wound and to modulate tumor-stroma interactions 
in carcinogenesis (16, 49, 50). By applying our newly devised strategy for discriminating 
between cleavage and non-cleavage events based on kinetic abundance profiles of neo-N-
terminal peptides, we selectively narrowed in on MMP10-dependent processing events. Sub-
classification not only revealed two distinct sub-clusters of less and more efficient cleavages, 
but also elucidated classes of cleaved proteins with distinct structural properties and 
functionalities. Interestingly, processing of collagens, the classical MMP substrates, was almost 
exclusively assigned to the group of less efficient cleavages, while non-collagen substrates 
were more efficiently cleaved. Notably, only the classical collagenase cleavage site in the type I 
collagen α2 chain was assigned to the cluster of efficient cleavages. Most identified MMP10-
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dependent collagen cleavages are presumably indirect rather than direct, particularly since the 
inability of this MMP to process type I collagen is well established (44). Our data indicate that 
the actual active collagenase in fibroblast secretomes upon incubation with MMP10 is MMP2, 
which has proven activity against type I collagen (43, 51). Supporting this hypothesis, two 
cleavage events identified in the type I collagen α1 and α2 chains, respectively, had also been 
detected in MMP2 degradomics studies (15, 20). However, although described as upstream 
activator of several proMMPs (52, 53), MMP10 does not directly activate MMP2 (53). This 
suggests activation of intermediate proteases or modulation of cofactors within the native 
fibroblast secretome upon incubation with active MMP10, leading to proteolytic conversion of 
proMMP2 to the active protease, which ultimately processes type I collagen. 
As a particularly interesting processing event, time-resolved 8plex-iTRAQ-TAILS identified 
cleavage of PDGFRα within its extracellular domain close to the plasma membrane, which is 
characteristic for receptor ectodomain shedding. Although dependent on MMP10, this cleavage 
was neither directly mediated by MMP10 nor by activated MMP2, indicating activity of an 
additional unknown protease. Interestingly, a disintegrin and metalloproteinase domain-
containing protein 10 (ADAM10) can shed the ectodomain of PDGFRβ (54), and a recent study 
described proteolytic activation of ADAM10 by meprin β through processing of the propeptide 
that remains bound to the active site after furin cleavage (55). Importantly, PDGFs and their 
receptors are pivotal players in controlling fibroblast proliferation and migration during 
cutaneous wound healing (56). Thus, ectodomain shedding of PDGFRα could be an additional 
mechanism to fine-tune activity of these potent growth factors by sequestering the active 
ligands. 
In contrast to PDGFRα, ADAMTSL1 is directly processed by MMP10 within a linker domain 
between thrombospondin domains 2 and 3 in very close proximity to a previously described 
putative cleavage site for an unknown serine protease (35). Concomitant processing by MMP2 
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presumably at the same site as MMP10 suggests a general susceptibility of this region to 
proteolysis, whereby overlapping activities for multiple MMPs have already been described for 
several substrates (15). So far, the functions of ADAMTSL1 and the closely related ADAMTSL3 
remain unknown. However, the C. elegans ortholog MADD4 has been implicated in midline-
oriented guidance of migrating cells (57), and a similar function of ADAMTSL1 might be 
modulated by MMP10-mediated processing. 
In conclusion, with time-resolved 8plex-iTRAQ-TAILS we introduce a workflow for substrate 
degradomics that significantly increases confidence in substrate identification and classifies 
cleavage sites by primary sequence and structural accessibility in secondary structure elements 
and multimeric higher-order structures, such as collagen fibrils. Moreover, time-resolved 
analysis of the MMP10 substrate degradome identified novel candidate substrates whose 
processing might mediate important MMP10 functions in tissue repair and carcinogenesis. 
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FIGURE LEGENDS 
Figure 1 High confidence identification of cleavage events by time-resolved abundance profiles. 
(A) Experimental setup. Secretomes from Balb/c 3T3 fibroblasts were incubated with GluC for 
increasing periods of time and analyzed by 8plex-iTRAQ-TAILS. Controls (c) were incubated 
with buffer alone for 0, 12 and 16 hours, respectively. (B) Peptide classification. GluC cleaves 
substrate proteins C-terminal to E and D residues generating neo-N and C termini that are 
monitored as semi-tryptic peptides (cleavage events) upon digest with the working protease 
trypsin (Trp). Concomitantly, trypsin releases internal tryptic peptides and natural N termini 
resembling non-cleavage events. Ac: acetylated. (C) Fuzzy c means clustering of abundance 
profiles of neo-N termini, quantifiable internal tryptic peptides and natural N termini. Peptides 
with a time-dependent increase in abundance after GluC incubation (cluster N.1) are separated 
from peptides with a relatively constant abundance over time (cluster N.2). Colorkey indicates 
membership value α. ctrl: 12 h and 16 h controls. (D) IceLogo analysis of cleavage sites 
corresponding to peptides in cluster N.1 and cluster N.2, respectively. High prevalence of E in 
P1 position indicates correct assignment of GluC-generated neo-N termini (cleavage events) to 
cluster N.1 with time-dependent increase in abundance. Peptides assigned to cluster N.2 (time-
independent) are either internal tryptic peptides (R in P1) or natural N termini (M in P1 (initiator 
methionine removed)). (E) Receiver Operating Characteristic (ROC) analysis to test 
performance of a classifier for cleavage events. The classifier is based on degree of 
membership (α) to the cluster of peptides with time-dependent increase in abundance. A high 
true positive rate at a low false positive rate indicates high performance. (F) Same analysis as in 
C but for neo-C termini. Colorkey indicates membership value α. ctrl: 12 h and 16 h controls. 
Figure 2 Kinetic sub-classification of cleavage site specificity and structural accessibility. (A) 
Sub-clustering of GluC-generated neo-N termini. Peptides assigned to cluster N.1 with a 
membership value of ≥0.8 were assigned to three sub-clusters with slow, medium and fast 
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increase in abundance upon GluC incubation. Colorkey indicates membership value α. ctrl: 12 h 
and 16 h controls. (B) IceLogo analysis of GluC cleavage sites corresponding to peptides 
assigned to each sub-cluster. Less efficient cleavages C-terminal to aspartate were assigned to 
sub-cluster N.1.1 comprising slow cleavage events, while medium and fast clusters comprised 
neo-N-terminal peptides derived from efficient cleavages after glutamate. (C) Secondary 
structure preferences for GluC cleavages in each sub-cluster. Secondary structure elements 
around the scissile bond were predicted by PROTEUS2 and aligned for cleavage sites in each 
sub-cluster. For all clusters only cleavages C-terminal to glutamate were included. High 
cleavage efficiency in sub-cluster N.1.3 is correlated with prevalence of extended loops. L: loop; 
A: helix; B: sheet. (D) Correlation of structural elements and cleavage efficiency within the same 
protein. Models from the SWISS-MODEL Repository for P63260 (left) and P60335 (right) based 
on templates 3ub5A (P63260), 2jzx (P60335; residues 11-169) and 1wvn (P60335; residues 
278-348), respectively. GluC cleavage sites identified by 8plex-iTRAQ-TAILS are indicated (P1 
(E): red; P1’: yellow). Cleavages in loops (PIYE167.168GYAL and VMLE168.169TLSQ) were more 
efficient than in a helix (EYDE364.365SGPS) or a beta sheet (TTHE283.284LTIP), indicating 
discrimination between secondary structure elements by time-resolved iTRAQ-TAILS analysis. 
Figure 3 Time-dependent decrease in abundance of cleavage site spanning peptides. (A) 
Categorization of cleavage events. Natural N termini and internal tryptic peptides harboring a 
single E or D in their sequence are decreased in abundance by internal cleavage (cleavage 
events). The same types of peptides with no internal E or D are not affected by GluC (non-
cleavage events). Solid line depicts cleaved natural N terminus and dashed line cleaved internal 
tryptic peptide. Black line indicates cleavage site spanning peptide, blue line neo-C and red line 
neo-N terminus. Trp: trypsin; Ac: acetylated. (B) Fuzzy c means clustering of abundance 
profiles of quantifiable cleavage site spanning peptides and non-cleaved internal tryptic peptides 
and natural N termini. Peptides with a time-dependent decrease in abundance after GluC 
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incubation (cluster I.1) are separated from peptides with a relatively constant abundance 
(cluster I.2). ctrl: 12 h and 16 h controls. (C) Time-resolved analysis of decrease in abundance 
of a cleavage site spanning peptide and concomitant increase of the corresponding neo-N and 
neo-C termini. (D) Secondary cleavage of neo-N termini harboring an internal E or D in their 
sequence. Cluster NE.4 represents neo-N termini with rapid increase in abundance at 2 to 4 
hours of GluC incubation and subsequent decrease upon secondary cleavage. For all clusters 
see Supplemental Figure S2. Colorkey indicates membership value α. ctrl: 12 h and 16 h 
controls. (E) Example for rapid generation of a neo-N terminus by GluC cleavage after E and 
slow appearance of an internal neo-N terminus by secondary processing after D. 
Figure 4 Time-resolved analysis of the MMP10 substrate degradome. (A) Experimental setup. 
Secretomes from Mmp10-/- MEFs were incubated with recombinant MMP10 or buffer (controls 
(c)) and analyzed by 8plex-iTRAQ-TAILS. (B) Peptides generated either by MMP10 and trypsin 
(Trp) (cleavage events; time-dependent) or by trypsin alone (non-cleavage events; time-
independent). Ac: acetylated. (C) Fuzzy c means clustering of abundance profiles of neo-N 
termini, quantifiable internal tryptic peptides and natural N termini. Peptides with a time-
dependent increase in abundance after MMP10 incubation (cluster M.1) are separated from 
peptides with a relatively constant abundance (cluster M.2). Peptides in cluster M.1 with 
abundances in control channels higher than 25% of the maximum abundance (grey) were 
omitted from subsequent analyses. Colorkey indicates membership value α. ctrl: 16 h control. 
(D) IceLogo analysis of cleavage sites corresponding to peptides in cluster M.1 and cluster M.2, 
respectively. High prevalence of P in P3 and/or L/I in P1’ positions for cleavages in cluster M.1 
(neo-N termini; time-dependent) correlate with an MMP cleavage specificity. Peptides assigned 
to cluster M.2 (time-independent) are mostly internal tryptic peptides (R in P1). 
Figure 5 Sub-classification of MMP10-dependent cleavage events. (A) Sub-clustering of 
MMP10-generated neo-N termini. Peptides assigned to cluster M.1 with a membership value of 
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≥0.9 were assigned to two sub-clusters with slow and fast increase in abundance upon MMP10 
incubation. Colorkey indicates membership value α. ctrl: 16 h control. (B) IceLogo analysis of 
cleavage sites corresponding to peptides assigned to sub-cluster M.1.1 and sub-cluster M.1.2, 
respectively. Low efficient cleavages in sub-cluster M.1.1 resemble the typical MMP cleavage 
motif GPXG.L/I in collagens. P in P3 and/or L/I in P1’ for cleavages in sub-cluster M.1.2 indicate 
MMP-dependent cleavage events. (C) Examples for proteins and MMP10-dependent cleavages 
in each sub-cluster. Predominant assignments of collagens to sub-cluster M.1.1 demonstrate 
slow processing of these structurally occluded cleavage sites. Only the canonical MMP 
cleavage site in the type I collagen α2 chain is processed with high efficiency as indicated by 
assignment to sub-cluster M.1.2. See Supplemental Table S9 for a full list of MMP10-dependent 
cleavages. (D) Kinetic profiles of cleavages in the collagen α2(I) chain. Time-resolved sub-
clustering distinguished the canonical MMP cleavage site (red) from additional MMP10-
dependent cleavages within the same collagen chain. (E) Validation of multiple processing of 
type I collagen and concomitant increase in abundance of active MMP2. Upper panel: 
Immunoblot analysis of MMP10 incubated secretomes from Mmp10-/- MEFs using an anti-
collagen I antibody showed appearance of cleavage fragments (arrows) with distinct kinetic 
profiles. Middle panel: Gelatin zymography revealed MMP10-dependent increase in abundance 
of a band matching the size of activated MMP2 (arrow) in MMP10 incubated secretomes. Lower 
panel: Immunoblot analysis of the same samples using an antibody directed against MMP2 
confirmed time-dependent activation of MMP2 (arrow) upon MMP10 incubation. 
Figure 6 Indirect processing of PDGFRα and direct cleavage of ADAMTSL1 by MMP10. (A) 
Domain structure of PDGFRα with annotated cleavage site in the extracellular domain, time-
dependent abundance profile of the generated neo-N terminus, and characterization of 
processing by incubation of recombinant proteins and immunoblot analysis of MMP10-incubated 
secretomes. Lack of cleavage of recombinant PDGFRα by MMP10 indicates indirect cleavage 
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in MMP10-incubated cell supernatants. (B) Domain structure of ADAMTSL1 (isoform 1) with 
annotated cleavage site in an extended loop between thrombospondin domains (TS) 2 and 3, 
time-dependent abundance profile of the generated neo-N terminus, and validation of 
processing by incubation of recombinant proteins. Detection of MMP10-generated fragments 
with expected molecular weights by silver stain and immunoblot analysis identified ADAMTSL1 
as a direct MMP10 substrate. 
Figure 7 Systems Biology Graphical Notation map of MMP10-dependent processing events. 
Activated MMP10 (propeptide removed; truncated) activates an unknown protease (reaction (re) 
8) that sheds the PDGFRα extracellular (ex_domain) from the intracellular (int_domain) domain 
(re6) interfacing with PDGFR signaling. Concomitantly, MMP10 activates an alternative 
protease (re10), which proteolytically activates MMP2 (re9) leading to type I collagen processing 
(re11). ADAMTSL1 is cleaved either by MMP10 or MMP2 (re5) in an N-terminal and a C-
terminal part comprising thrombospondin domains 1 and 2 (TS1_2) and 3 and 4 (TS3_4), 
respectively. 
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